Les e-cigarettes ou vapoteuses aromatisées au cannabis reflètent une nouvelle tendance de la consommation de substances chez les adolescents, constate cette étude menée par des épidémiologistes et des ...
Tekton Research, a leading multi-site clinical trial company, is proud to announce the addition of three new sites, five new Principal Investigators (PIs), and a renowned CNS Consultant to its ...
Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company focused on keeping cancer patients alive, today announced that it will host a conference call and live webcast at 8:30 am ET ...
SEATTLE, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Shape Therapeutics, a leader in RNA-based gene therapy, today announced the acceptance of two oral presentations at the upcoming European Society of Gene ...
ZUG, Switzerland, Sept. 26, 2025 (GLOBE NEWSWIRE) -- The attached notification relates to trades entered into by a PDMR of the Company pursuant to a 10b5-1 trading plan, in accordance with Rule 10b5-1 ...
BENTONVILLE, Ark., Sept. 26, 2025 (GLOBE NEWSWIRE) -- Glucose Health, Inc. (OTC: GLUC) today announced that its Chief Executive Officer and Chief Financial Officer has resigned, effective September 30 ...
ZTlido® is a registered trademark owned by Scilex Pharmaceuticals Inc., a wholly-owned subsidiary of Scilex Holding Company. Gloperba® is the subject of an exclusive, transferable license to use the ...
This award strongly validates our approach to Alzheimer’s disease,” said Dr. Carmela Abraham, Chief Science Officer. “With NIH support, we are one step closer to helping patients suffering from this ...
Le Gala offrira des témoignages émouvants de patients, des prestations artistiques enlevantes, des vidéos commémoratives, un repas de fine gastronomie et des rencontres inspirantes avec des patients ...
People wear nylon and polyester daily, unaware that their clothing could be releasing invisible plastic particles directly onto their skin or into the air they breathe. Spider silk offers a safer, ...
CARSON CITY, Nev., Sept. 26, 2025 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for neurological and ...
The Gala will feature moving patient stories, captivating artistic performances, commemorative videos, gourmet dining, and inspiring encounters with current and former patients— all in celebration of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback